NCT07571590Not yet recruiting
Effectiveness of a Self-Efficacy Based Educational Program on Glycemic Self-Monitoring, Diabetes Self-Management Knowledge, and Health-Related Quality of Life Among Adults With Type 2 Diabetes Mellitus
Effectiveness of a Self-Efficacy-Based Educational Program on Glycemic Self-Monitoring, Diabetes Self-Management Knowledge, and Health-Related Quality of Life Among Adults With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 6 May 2026
Brief summary (registry, in English)
This randomized controlled trial aims to evaluate the effectiveness of a self-efficacy-based educational program on glycemic self-monitoring, diabetes self-management knowledge, and health-related quality of life among adults with Type 2 Diabetes Mellitus. Participants will be randomly assigned to either an intervention group receiving the educational program or a control group receiving standard care. The educational program is designed to enhance patients' confidence (self-efficacy) in managing their condition, including blood glucose monitoring, adherence to treatment, lifestyle modification, and self-care practices. Outcomes will be assessed using validated tools to measure improvements in self-monitoring behaviors, knowledge, and quality of life. The findings of this study are expected to provide evidence on the effectiveness of educational interventions in improving diabetes management and patient outcomes.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- First submitted
- 24 Apr 2026
- Start date
- 1 May 2026
- Primary completion date
- 1 May 2026
- Lead sponsor
- Jerash Private University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07571590
What you commit to
- Study type: Interventional
- Planned participants: 400
- From 1 May 2026 to the primary completion date, 1 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with Type 1 diabetes mellitus or gestational diabetes
- Patients with severe medical conditions such as renal failure or cardiovascular instability that may affect participation
- Patients with other conditions that may hinder study participation
Lab values
- Patients currently using corticosteroid medications due to their effect on blood glucose levels
Other
- Patients with physical or cognitive impairments that limit the ability to perform SMBG independently
- Pregnant or lactating women
- Patients who do not provide informed consent
- Patients who fail to respond to study instruments
- Patients who participated in similar educational programs within the past six months
Who the study is looking for
- Adults aged 18 years and above
- Diagnosed with Type 2 Diabetes Mellitus (T2DM)
- Attending Jordanian Ministry of Health healthcare facilities for at least six months with regular follow-up visits
- Able to perform or learn self-monitoring of blood glucose (SMBG)
- Able to use a glucometer independently
- Willing to participate and provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ministry of Health Primary Healthcare Centers Coordinator of this site? Confirm its status | Jerash | Jordan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.